289 related articles for article (PubMed ID: 12916522)
1. [Long-term therapy with clopidogrel in combination with ASA significantly reduces risk of death, myocardial infarct or stroke].
Minerva Med; 2003 Apr; 94(2):XIII-IV. PubMed ID: 12916522
[No Abstract] [Full Text] [Related]
2. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of ischemic heart disease with the platelet aggregation inhibitor clopidogrel].
Helø OH; Madsen JK; Kastrup J
Ugeskr Laeger; 2004 Apr; 166(18):1659-62. PubMed ID: 15174400
[No Abstract] [Full Text] [Related]
4. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
Reaume KT; Regal RE; Dorsch MP
Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394
[TBL] [Abstract][Full Text] [Related]
5. [Clopidogrel as basic therapy in high-risk stroke patients].
Mattle HP
Praxis (Bern 1994); 2004 Aug; 93(34):1364. PubMed ID: 15468694
[No Abstract] [Full Text] [Related]
6. Secondary stroke prevention set to benefit from PRoFESS trial: extended-release dipyridamole plus aspirin (Asasantin Retard) and clopidogrel share very similar benefit-risk ratio in vascular prevention.
Cardiovasc J Afr; 2008; 19(3):165. PubMed ID: 18568182
[No Abstract] [Full Text] [Related]
7. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
Fox KA; Mehta SR; Peters R; Zhao F; Lakkis N; Gersh BJ; Yusuf S;
Circulation; 2004 Sep; 110(10):1202-8. PubMed ID: 15313956
[TBL] [Abstract][Full Text] [Related]
8. Aspirin + clopidogrel therapy: how does your care compare to the evidence?
Simmons BB; Salzman BE
J Fam Pract; 2008 Jan; 57(1):26-32. PubMed ID: 18171566
[No Abstract] [Full Text] [Related]
9. Antiplatelet therapy in the treatment of atherothrombotic disease: considering the evidence.
Aronow WS
Geriatrics; 2007 Apr; 62(4):12-24. PubMed ID: 17408314
[TBL] [Abstract][Full Text] [Related]
10. Is ticlopidine more effective than aspirin in preventing adverse cardiovascular events after myocardial infarction (MI)?
Olson J; Huntington J
J Fam Pract; 2001 Jul; 50(7):623. PubMed ID: 11485713
[No Abstract] [Full Text] [Related]
11. Combination antiplatelet agents for secondary prevention of ischemic stroke.
Vande Griend JP; Saseen JJ
Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
[TBL] [Abstract][Full Text] [Related]
12. Clopidogrel in addition to aspirin reduces one-year major adverse cardiac and cerebrovascular events in unselected patients with non-ST segment elevation myocardial infarction.
Zeymer U; Gitt AK; Zahn R; Jünger C; Bauer T; Köth O; Heer T; Wienbergen H; Gottwik M; Senges J
Acute Card Care; 2008; 10(1):43-8. PubMed ID: 17924233
[TBL] [Abstract][Full Text] [Related]
13. Clopidogrel in addition to aspirin reduces in-hospital major cardiac and cerebrovascular events in unselected patients with acute ST segment elevation myocardial.
Zeymer U; Gitt A; Jünger C; Bauer T; Heer T; Koeth O; Mark B; Zahn R; Senges J; Gottwik M
Thromb Haemost; 2008 Jan; 99(1):155-60. PubMed ID: 18217148
[TBL] [Abstract][Full Text] [Related]
14. Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
Beinart SC; Kolm P; Veledar E; Zhang Z; Mahoney EM; Bouin O; Gabriel S; Jackson J; Chen R; Caro J; Steinhubl S; Topol E; Weintraub WS
J Am Coll Cardiol; 2005 Sep; 46(5):761-9. PubMed ID: 16139122
[TBL] [Abstract][Full Text] [Related]
15. Evolving perspectives on clopidogrel in the treatment of ischemic stroke.
Gorelick P; Sechenova O; Hennekens CH
J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):245-8. PubMed ID: 17220470
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet agents and randomized trials.
Diener HC
Rev Neurol Dis; 2007; 4(4):177-83. PubMed ID: 18195669
[TBL] [Abstract][Full Text] [Related]
17. Clopidogrel: who, when, and how?
Cannon CP
Rev Cardiovasc Med; 2007; 8 Suppl 3():S27-34. PubMed ID: 17917618
[TBL] [Abstract][Full Text] [Related]
18. [Secondary stroke prevention according to the PRoFESS Study. What are the sequelae for practical therapy?].
Diener C
MMW Fortschr Med; 2008 May; 150(21):7. PubMed ID: 18578065
[No Abstract] [Full Text] [Related]
19. Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation.
Wolak A; Amit G; Cafri C; Gilutz H; Ilia R; Zahger D
Int J Cardiol; 2005 Sep; 103(3):293-7. PubMed ID: 16098392
[TBL] [Abstract][Full Text] [Related]
20. [ASS plus dipyridamole or clopidogrel after stroke: what is the best secondary prevention?].
Einecke D
MMW Fortschr Med; 2008 May; 150(21):6-7. PubMed ID: 18575244
[No Abstract] [Full Text] [Related]
[Next] [New Search]